Impact of the PATH Statement on Analysis and Reporting of Heterogeneity of Treatment Effect in Clinical Trials: A Scoping Review.

Joe V SelbyCarolien C H M MaasBruce H FiremanDavid M Kent

Published in: medRxiv : the preprint server for health sciences (2024)

The PATH Statement appears to be influencing research practice. Risk modeling often uncovered clinically important HTE; effect modeling was more often exploratory.

Keyphrases

clinical trial
healthcare
primary care
emergency department
randomized controlled trial
adverse drug
quality improvement
open label
phase ii
drug induced